Key Takeaways
- A Missouri circuit court granted preliminary approval for a $7.25 billion settlement to resolve Bayer Roundup litigation.
- The agreement covers both current and potential future claims related to non-Hodgkin lymphoma injuries.
- Potential class members have until June 4, 2026, to opt out or file objections to the proposed terms.
- A final fairness hearing is scheduled for July 9, 2026, to determine the settlement's ultimate status.
- The settlement remains independent of the U.S. Supreme Court’s review of federal preemption in the Durnell case.
Bayer Roundup Settlement Receives Preliminary Court Approval
A judge in the Circuit Court of the City of St. Louis, Missouri, has granted preliminary approval for a class action settlement involving Bayer Roundup. This ruling, issued on March 4, 2026, marks a significant development in the company's efforts to resolve litigation alleging that the herbicide caused non-Hodgkin lymphoma (NHL). The settlement, valued at approximately $7.25 billion, was proposed by leading plaintiff law firms to address both existing and future claims.
“We are pleased the Court granted preliminary approval of the class settlement, which is designed to resolve current and potential future Roundup claims relating to NHL,” said Bill Dodero, Senior Vice President and General Counsel of Bayer. “This is the first major step in putting this settlement into effect, and we remain confident that the long-term and well-financed class settlement plan warrants final approval by the court.”
Timeline for the Bayer Roundup Fairness Hearing
The court’s order initiates a formal notification process for potential class members nationwide. Following the preliminary approval, a 90-day period is now underway, ending on June 4, 2026. During this time, individuals may choose to opt out of the settlement or file formal objections.
